APP and Alzheimer disease: Both the SCFAs content in the feces and the serum was significantly reduced in APP/PS1 mice, which is consistent with relevant research findings (Nandwana et al., 2022), indicating that the pathological changes in SCFAs in 6-month-old APP/PS1 mice are associated with a decrease in the number of SCFAs in AD and can serve as effective research objects.